DAFTAR PUSTAKA
Abosaif NY, Tolba YA, Heap M.The outcome of acute renal failure in the intensive care unit according to RIFLE: model applicability, sensitivity, and predictability.Am J Kidney Dis 2005; Vol. 46: 1038–48.
Abraham E, Singer M: Mechanisms of sepsis-induced organ dysfunction.Crit Care Med.2007; 35:2408-2416.
Ali T, Khan I, Simpson W.Incidence and outcomes in acute kidney injury: a comprehensive population-based study.J Am Soc Nephro 2007; Vol. 18: 1292–8.
Aydogdu M, Gursel G, SancakB, et al. The Use Of Plasma And Urine
Neutrophil Gelatinase Associated Lipocalin (NGAL) And Cystatin C In
Early Diagnosis Of Septic Acute Kidney Injury In Critically Ill
Patients. Disease Markers 2013: 34: 237-246.
Bagshaw SM, Langenberg C, Wan L, May CN, Bellomo R: A systematic review of urinary findings in experimental septic acute renal failure. Crit Care Med. 2007;35: 1592–1598.
Bagshaw SM, Uchino S, Bellomo R.Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol
2007; Vol. 2: 431-439.
Bellomo R, Ronco C, Kellum JA.Acute renal failure - definition, outcome
measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. s.l. Crit Care 2004; Vol. 8. Bengatta S, Arnould C, Letavernier E,Monge M, de Preneuf HM, Werb Z,
Ronco P,
Berglund F, Killander J, Pompeius R. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol 1975;114:802-8. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated,
blood flow abnormalities in septic and critically ill patients using a newly designed in dwelling thermodilution renal vein catheter.Chest. 1990;98: 170–179.
Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol. 2003; 14 (suppl 1): S55–61 Bradley VE, Shier MR, Lucas CE, Rosenberg IK: Renal hemodynamic
response to furosemide in septic and injured patients. Surgery. 1976; 79: 549–554.
Brenner M, Schaer GL, Mallory DL, Suffredini AF, Parrillo JE: Detection of renal
Chung MY, Won Jun D, Sung SA. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. The Korean Journal of Hepatology. 2010; 16: 301-7
Dai X, Zeng Z, Fu C, et al. Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury. Critical care. 2015; 19:223.
De laet I, Malbrain ML, Jadoul JL.Renal implications of increased intraabdominal pressure: are the kidneys the canary for abdominal hypertension? Acta Clin Belg Suppl 2007; 3: 119-30
de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F: Acute renal failure in the ICU: Risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000;26: 915–21
De Vriese AS, Bourgeois M: Pharmacologictreatment of acute renal failure in sepsis. Curr Opin Crit Care. 2003;9: 474–480.
Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: An update and primer for the intensivist Denver. Crit Care Med 2010; Vol 38
morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; Vol. 11: 127.
Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008; 241; 89-94.
Devarajan P.Emerging Biomarkers of Acute Kidney Injury. Bellomo R,
editors. Acute Kidney Injury. Basel: Karger AG; 2007.p.203-9.
Devarajan P.Neutrophil gelatinase-associated Lipocalin: An emerging troponin for kidney injury.. Nephrol Dial Transplant 2008; Vol. 23: 3737-43
Doi K, Peter ST, Eisner C, et al. Reduced production of creatinine limits its use as a marker of kidney injury in sepsis. J Am Soc Nephrol 2009; 20: 1217-21.
Grigoryev DN, Liu M, Hassoun HT, CheadleC, Barnes KC, Rabb H: The local and systemic inflammatory transcriptome afteracute kidney injury. J Am Soc Nephrol. 2008;19: 547–558.
Grootaert V, Willems L, Debaveye Y, Meyfroidt G, Spriet I. Augmented renal clearance in the critically ill: how to assess kidney function. Ann Pharmacother. 2012; 46(7-8): 952-9.
Han WK, Bailly V, Abichandani R, Thadani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; Vol. 62: 237-44..
Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, et al. Early detection of acute renal failure by serum cystatin C.Kidney Int 2004; Vol. 66: 1115-22.
Heyman SN, Brezis M, Epstein FH.Effect of glycine and hypertrophy on renal outer medullary hypoxic injury in ischemia reflow and contrast nephropathy. Am J Kidney Dis 1992;, Vol. 19: 578–86.
Jafar TH, Chaturvedi N, Gul A, Khan AQ, Schmid CH, Levey AS. Ethnic differences and determinants of proteinuria among South Asian subgroups in Pakistan. Kidney Int 2603;64:1437-44.
Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998;32:992-9. [Erratum, Am J Kidney Dis 2000;35:178.]
Kellum JA, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, et al. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements 2012; Vol. 2: 3-4.
Kellum JA, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, et al. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements 2012; Vol. 2: 3-4.
Kellum JA, Srisawat N.Acute Kidney Injury – Definition and Classification. European Critical Care & Emergency Medicine. 2010; 5: 102-6.
Langenberg C, Bellomo R, May C, Wan L,Egi M, Morgera S: Renal blood flow in sepsis.Crit Care. 2005;9: R363–R374.
Langenberg C, Wan L, Egi M, May CN, Bellomo R: Renal blood flow and function during recovery from experimental septic acute kidney injury. Intensive Care Med. 2007;33: 1614–1618.
Langenberg C, Wan L, Egi M, May CN, Bellomo R: Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006;69: 1996– 2002.
Lassnigg A, Schmidlin D, Mouhieddine M.Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol 2004; Vol. 15: 1597-1605. Lelongt B: MMP9 and SCF protect from apoptosisin acute kidney injury. J Am
Soc Nephrol. 2009;20: 787–797.
Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990;38:167-84.
Liangos O, Han WK, Wald R, Perianayagam MC, Mackinnon RW, Dolan N, et al.Urinary kidney injury molecule-1 level is an early and sensitive marker of acute kidney injury following cardiopulmonary bypass. J Am Soc Nephrol 2006; Vol. 17: 403
Licari E, Calzavacca P, Ronco C, Bellomo R: Fluid resuscitation and the septic kidney: The evidence. Contrib Nephrol. 2007;156: 167– 177.
Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L. Thyroid function
differently affects serum cystatin C and creatinine concentrations. J
Endocrinol Invest. 2005;28: 346-349.
Martins PS, Brunialti MK, da Luz FernandesM, Martos LS, Gomes NE, Rigato O, SalomaoR: Bacterial recognition and inducedcell activation in sepsis. Endocr Metab ImmuneDisord Drug Targets. 2006;6: 183–191. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et
al.Acute Kidney Injury Network: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; Vol. 11: 31.
Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb, J, Ikizler TA, et al.Program to improve Care in Acute Renal Disease:Spectrum of acute renal failure in the intensve care unit:The PICARD experience. s.l. : Kidney Int 2004; Vol. 66.
Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, et al. Impaired IL-18 processing protects caspase-1 deficient mice from ischemic acute renal failure. J Clin Invest 2001; Vol. 107: 1145-52. Mishra J, Dent C, Tarabishi R. Neutrophil gelatinase-associated lipocalin
(NGAL) as a biomarker for acute renal injury after crdiac surgery.s.l. : Lancet 2005; Vol. 365: 1231-38.
Mohanram A, Toto R. Measurementof kidney function. In: Pereira BJG, Sayegh MH, Blake PG, eds. Chronic kidney disease, dialysis, and transplantation: a companion to Brenner and Rector’s The Kidney. Philadelphia: Saunders, 2005:20-30.
Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J.Technology insight: Biomarker development in acute kidney injury – What can we anticipate?. Nat Clin Pract Nephrol 2008; Vol. 4: 154-65.-165.
Monneret G, Venet F, Pachot A, Lepape A:Monitoring immune dysfunctions in the septicpatient: A new skin for the old ceremony.Mol Med. 2008;14: 64–78.
Mori K, Lee HT, Rapoport D, Drexler I, Foster K, Yang J, et al.Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; Vol. 115: 610-21 Munford RS, Pugin J: Normal responses toinjury prevent systemic
inflammation andcan be immunosuppressive. Am J Respir CritCare Med. 2001;163: 316–321.
of septic acute kidney injury: What do wereally know? Crit Care Med. 2008;36: S198–S203.
Okusawa S, Gelfand JA, Ikejima T, ConnollyRJ, Dinarello CA: Interleukin 1 induces a
Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005: Vol. 16: 3046-52.
Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, et al.
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery.Kidney Int 2006; Vol. 70: 199-203
Parker MM, Shelhamer JH, Natanson C,Alling DW, Parrillo JE: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an earlypredictor of prognosis. Crit Care Med. 1987;15: 923–929.
Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, et al. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT).. s.l. : Minerva Anestesiol 2011; Vol. 77
RC, Blantz.Pathophysiology of pre-renal azotemia. Kidney International 1998; Vol. 53: 512-513.
Rittirsch D, Hoesel LM, Ward PA: The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007;81: 137– 143.
Royakkers AA, Korevaar JC, Van Suijlen JD, Hofstra LS, Kuiper MA, Spronk PE, et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med. 2011; 37: 493–501.
Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapyThe Journal of Clinical Investigation 2004; Vol.114: 10-14.
Schrier RW.Need to intervene in established acute renal failure.. J Am Soc Nephrol 2004; Vol. 15: 2756-8.
Sharfuddin AA, Sandoval RM, Berg DT, Mc-Dougal GE, Campos SB, Phillips CL, Jones BE,Gupta A, Grinnell BW, Molitoris BA: Soluble thrombo modulin protects ischemic kidneys. J Am Soc Nephrol. 2009;20: 524– 534.
shock-like state in rabbits: Synergism withtumor necrosis factor and the effect of cyclooxygenaseinhibition. J Clin Invest. 1988;81: 1162–1172.
Slort PR, Ozden N, Pape L, Offner G, Tromp WF, Wilhelm AJ, et al.
Comparing cystatin C and creatinine in the diagnosis of pediatric acute
renal allograft dysfunction. Pediatr Nephrol. 2012; 27: 843–9
Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am 2005;89:457-73.
Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996; 334: 1448–60.
Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med . 1995; 21(suppl 2): S258–63
Tracey KJ, Beutler B, Lowry SF, MerryweatherJ, Wolpe S, Milsark IW, Hariri RJ,Fahey TJ, 3rd, Zentella A, Albert JD, ShiresGT, Cerami A: Shock and tissue injury inducedby recombinant human cachectin.Science. 1986;234: 470–474.
Uchino S, Bellomo R, Goldsmith D.An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.Crit Care Med 2006; Vol. 34: 1913–7
Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critical ill patients: a multinational, multicenter study. JAMA. 2005; 294(7):813-8.
Uchino S, Kellum JA, Bellomo R.Acute renal failure in critically ill patients: A multinational, multicenter study. 2005, Jama 2005; Vol. 294: 813-8 Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney
injury.Ann Rev Pharmacol Toxicol 2008; Vol. 48: 463-93.
Villa P, Jiménez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Critical Care.2005; 9: 139-43
Vivino G, Antonelli M, Moro ML.Risk factors for acute renal failure in trauma
patients. Intensive Care Med 1998; Vol. 24: 808-14
Wesson L. Physiology of the human kidney. New York: Grune & Stratton, 1969.
Wheeler Derek S, Devarajan P, Ma Q, et al. Serum Neutrophil Gelatinase-associated Lipocalin (NGAL) as a Marker of Acute Kidney Injury in Critically Ill Children with Septic Shock. Crit Care Med. 2008; 36(4); 2=1297-1303.
Xu S, Venge P. Lipocalins as biochemical markers of disease.. Biochim Biophys Acta 2000; Vol. 1482: 298-307.
Yegenaga I, Hoste E, Van Biesen W, Vanholder R, Benoit D, Kantarci G, Dhondt A, Colardyn F, Lameire N: Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: Results of a prospective study. Am J Kidney Dis 2004;43: 817–24.
